4.3 Review

Salivary Biomarkers for Clinical Applications

期刊

MOLECULAR DIAGNOSIS & THERAPY
卷 13, 期 4, 页码 245-259

出版社

ADIS INT LTD
DOI: 10.1007/BF03256330

关键词

-

资金

  1. US National Institutes of Health/NIDCR [U01-DE16275, U01-DE17790, R01-DE17170]
  2. Felix and Mildred Yip Endowed Professorship Fund
  3. RNAmeTRIX Inc
  4. NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017170, U01DE016275, U01DE017790] Funding Source: NIH RePORTER

向作者/读者索取更多资源

For clinical applications Such its monitoring health Status. disease onset and progression, and treatment outcome. there are three necessary prerequisites: (i) a Simple method for collecting biologic samples, ideally noninvasively, (ii) specific biomarkers associated with health or disease; and (III) a technology platform to rapidly utilize the biomarkers. Saliva, often regarded as the 'mirror of the body', is it perfect surrogate medium to be applied for clinical diagnostics. Saliva is readily accessible via a totally noninvasive method. Salivary biomarkers, whether produced by healthy individuals or by individuals affected by specific diseases, are sentinel molecules that Could be used to scrutinize health and disease surveillance. The visionary investment by the US National Institute of Dental and Craniofacial Research, the discovery of salivary biomarkers, and the ongoing development of salivary diagnostic technologies have addressed its diagnostic value For clinical applications. The availability of more sophisticated analytic techniques gives optimism that saliva can eventually be placed its a biomedium for clinical diagnostics. This review presents current salivary biomarker research and technology developmental efforts for clinical applications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据